Evaluation of Depression and Anxiety in Rheumatoid Arthritis Patients During COVID-19 Pandemic

CONCLUSIONS: It was observed that patients diagnosed with RA revealed a higher prevalence of COVID-19 infection. The occurrence of depression and anxiety was observed to be widespread among patients diagnosed with RA and, more significantly, prevalent in RA patients who had a recent COVID-19 and had a higher level of disease activity. The occurrence of COVID-19 and disease duration were identified as factors that can anticipate the development of depression and anxiety.PMID:38115857 | PMC:PMC10729612 | DOI:10.1177/11795441231216988
Source: Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders - Category: Orthopaedics Authors: Source Type: research